EARNING RECAP

Ctrip.com International Ltd

#CTRP 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 13c est. (3c) $1.1B est. $1.07B +19.78% ($41.91 closing price) $43 $39.28 backs Q1 net revenue growth view of 18%- 23%; est for Q1 revenue $1.19B
Q3 non GAAP 42c est. 27c $1.4B est. $1.34B -19.02% ($27.89 closing) $29.84 $27.50 sees Q4 revenue growth 15%- 20%, est. $1.08B
Q2 adjusted 29c est. 20c $1.11B est. $1.06B +5.43% ($38.98 closing price) $39.82 $38.31 sees Q3 revenue growth of 13%- 18% from last year; Q2 operating margin 16% vs. 14% in Q1
Q1 adjusted per ADS 55c may not compare to 16c $1.1B est. $1.05B +3.98% ($45.17 closing) $46.74 $44.62 sees Q2 revenue growth of 12% -17%;
#CTRP 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 adjusted 24c est. 16c $980M est. $1B -1.95% ($47.78 closing) $49.90 $47.14 sees Q1 revenue growth roughly 9%-11% est. $1.11B
Q3 adjusted 41c vs 24c $1.2B vs $1.15B -2.29% ($46.46 closing) $47.49 $44.57 Sees Q4 net revenue growth 25%-30%, consensus $996.5M
Q2 22c vs. 20c $946M vs. $945.07 -2.41% $51.97 $48.62
Q1 16C vs 7c $884M vs $886.55M -3.53% ($54.15 closing) $54.79 $52.72 -4.24% @ $53.75 AH. reports Q1 gross margin 80%

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.